Guidelines for Using New Anti-Seizure Medications in Epilepsy
Researchers studied the use of third-generation anti-seizure medications (ASMs) to treat epilepsy.
Epilepsy genetics explained: Explore epilepsy genetics in plain language. What key genes mean, how testing works, and what families should know.
Researchers studied the use of third-generation anti-seizure medications (ASMs) to treat epilepsy.
This study focused on people in Martinique who experienced status epilepticus (SE), a serious condition where seizures last too long or occur repeatedly without recovery.
This study focused on children with Tuberous Sclerosis Complex (TSC), a genetic condition that can cause various health issues, including tumors in different organs and early-onset epilepsy.
A study was conducted to understand the characteristics and treatment outcomes of epilepsy related to the NPRL3 gene.
This study looked at how effective a virtual training program was for neurology trainees in Canada learning about epilepsy.
This study looked at the cost-effectiveness of a medication called brivaracetam (BRV) for treating patients in Jordan who have focal-onset seizures that do not respond to other treatments.
Researchers studied how brain activity changes during sleep by looking at a specific type of electrical signal called aperiodic activity.
Researchers studied a new method for detecting infantile spasms (IS), a serious type of epilepsy that occurs in young children.
A recent study looked at how doctors in Germany, Austria, and Switzerland treat a serious condition called status epilepticus (SE), which is a prolonged seizure that can be life-threatening.